Recursion Pharmaceuticals (NASDAQ:RXRX) CEO Najat Khan Sells 23,588 Shares of Stock
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX – Get Free Report) CEO Najat Khan sold 23,588 shares of Recursion Pharmaceuticals stock in a transaction that occurred on Friday, June 5th. The shares were sold at an average price of $3.58, for a total value of $84,445.04. Following the sale, the chief executive officer directly owned 2,175,796 shares in […]
6 Jun 12:32 · The Markets Daily